Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
ULTRAtab Laboratories, Inc.

ULTRAtab Laboratories, Inc. Recalls

All product recalls associated with ULTRAtab Laboratories, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Jan 2022

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 21–34 of 34 recalls

Back Relief II (ULTRAtab) – Manufacturing Deviation (2022)

CGMP Deviations

Class IIModerate

FDAJan 26, 2022Nationwide• ULTRAtab Laboratories, Inc.

APAP 500mg Tablets (ULTRAtab) – Manufacturing Deviation (2022)

CGMP Deviations

Class IIModerate

FDAJan 26, 2022Nationwide• ULTRAtab Laboratories, Inc.

Coated Back Relief Tablet (ULTRAtab) – Manufacturing Deviation (2022)

CGMP Deviations

Class IIModerate

FDA

Page 2 of 2Next

Jan 26, 2022

Nationwide

• ULTRAtab Laboratories, Inc.

Dologen 325 Caplet (ULTRAtab) – manufacturing deviation (2022)

CGMP Deviations

Class IIModerate

FDAJan 26, 2022Nationwide• ULTRAtab Laboratories, Inc.

Migrenol Caplet (ULTRAtab) – Quality Control Issue (2022)

CGMP Deviations

Class IIModerate

FDAJan 26, 2022Nationwide• ULTRAtab Laboratories, Inc.

APAP 500mg Caplet (ULTRAtab) – Manufacturing Deviation (2022)

CGMP Deviations

Class IIModerate

FDAJan 26, 2022Nationwide• ULTRAtab Laboratories, Inc.

Kramer Novis Tusicof Caplet (ULTRAtab) – Quality Control Issue (2022)

CGMP Deviations

Class IIModerate

FDAJan 26, 2022Nationwide• ULTRAtab Laboratories, Inc.

Cystex Tablet (ULTRAtab) – Quality Control Issue (2022)

CGMP Deviations

Class IIModerate

FDAJan 26, 2022Nationwide• ULTRAtab Laboratories, Inc.

Normed Fem Tablet (ULTRAtab) – Quality Deviation (2022)

CGMP Deviations

Class IIModerate

FDAJan 26, 2022Nationwide• ULTRAtab Laboratories, Inc.

Phenylephrine HCl Tablet (ULTRAtab) – Quality Deviation (2022)

CGMP Deviations

Class IIModerate

FDAJan 26, 2022Nationwide• ULTRAtab Laboratories, Inc.

APAP/Phenylephrine Tablets (ULTRAtab) – Manufacturing Deviation (2022)

CGMP Deviations

Class IIModerate

FDAJan 26, 2022Nationwide• ULTRAtab Laboratories, Inc.

Spearmint Antacid Tablet (ULTRAtab) – manufacturing deviation (2022)

CGMP Deviations

Class IIModerate

FDAJan 26, 2022Nationwide• ULTRAtab Laboratories, Inc.

DBI Magnums Tablet (ULTRAtab) – Quality Control Issue (2022)

CGMP Deviations

Class IIModerate

FDAJan 26, 2022Nationwide• ULTRAtab Laboratories, Inc.

PAIN AID ESF- (ULTRAtab) – Laboratory Investigation (2021)

CGMP Deviations: failed stability results, inadequate laboratory investigations,

Class IIModerate

FDANov 29, 2021Nationwide• ULTRAtab Laboratories, Inc.